Related Experiment Video
Updated: Dec 30, 2025
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
Published on: October 10, 2025
Bacterial Baptism: Scientific, Medical, and Regulatory Issues Raised by Vaginal Seeding of C-Section-Born Babies
Noel T Mueller1, Suchitra K Hourigan1, Diane E Hoffmann1
1Noel T. Mueller, Ph.D., M.P.H., is an Assistant Professor of Medicine, Johns Hopkins Bloomberg School of Public Health. Suchitra K. Hourigan, M.D., is a Pediatric Gastroenterology & Pediatrics, INOVA Health. Diane E. Hoffmann, J.D., Sc.M., is a Professor of Law, University of Maryland Carey School of Law. Lauren Levy, J.D., M.P.H., is Health Officer, Cecil County, MD Health Department. Erik C. von Rosenvinge, M.D., is an Associate Professor, Medicine, University of Maryland School of Medicine; Chief of Gastroenterology, VA Maryland Health Care System. Betty Chou, M.D., is an Assistant Professor of Gynecology and Obstetrics, Johns Hopkins University School of Medicine. Maria-Gloria Dominguez-Bello, Ph.D., is a Professor, Dept. of Biochemistry and Microbiology, Rutgers School of Environmental and Biological Sciences.
Insights
Cesarean section (C-section) infants may face health risks. Vaginal seeding aims to transfer maternal microbes, but more research is needed to confirm health benefits.
Area of Science:
- Microbiome research
- Pediatric health
- Obstetrics
Background:
- Infants born via Cesarean section (C-section) exhibit increased risks for allergies, asthma, and obesity.
- The maternal microbiome plays a crucial role in infant development and immune system establishment.
- C-section delivery disrupts the natural transfer of maternal microbes to the infant.
Purpose of the Study:
- To review current research on vaginal seeding for C-section infants.
- To explore the potential of vaginal seeding in restoring the infant microbiome.
- To discuss the implications of vaginal seeding for medical professionals and patients.
Main Methods:
- Review of existing scientific literature on vaginal seeding.
- Analysis of preliminary evidence regarding microbial transfer.
- Discussion of ongoing clinical trials and their objectives.
Main Results:
- Preliminary evidence suggests vaginal seeding can partially restore the infant's microbial composition.
- The long-term health benefits of vaginal seeding remain undetermined.
- Growing clinical interest and patient demand for the procedure are noted.
Conclusions:
- Vaginal seeding is a proposed method to mitigate C-section-related health risks by transferring maternal microbes.
- Further robust scientific evidence is required to validate the efficacy and safety of vaginal seeding.
- The procedure presents complex considerations for regulatory bodies, researchers, clinicians, and expectant parents.
Abstract:
Several lines of evidence suggest that children born via Cesarean section (C-section) are at greater risk for adverse health outcomes including allergies, asthma and obesity. Vaginal seeding is a medical procedure in which infants born by C-section are swabbed immediately after birth with vaginal secretions from the mother. This procedure has been proposed as a way to transfer the mother's vaginal microbiome to the child, thereby restoring the natural exposure that occurs during vaginal birth that is interrupted in the case of babies born via C-section. Preliminary evidence indicates partial restoration of microbes. However, there is insufficient evidence to determine the health benefits of the procedure. Several studies, including trial, are currently underway. At the same time, in the clinic setting, doctors are increasingly being asked to by expectant mothers to have their babies seeded. This article reports on the current research on this procedure and the issues it raises for regulators, researchers, physicians, and patients.
Related Concept Videos
01:59CRISPR
01:07Teratogenicity